| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/14/2011 | US7960118 EGFR mutations |
| 06/14/2011 | US7960113 DNA analysis method and DNA analyzer |
| 06/14/2011 | US7960111 NALP7-based diagnosis of female reproductive conditions |
| 06/14/2011 | US7960107 Method of determining the susceptibility of a subject to developing insulin-dependent diabetes |
| 06/14/2011 | US7960105 Method of DNA analysis using micro/nanochannel |
| 06/14/2011 | US7960102 Regulated aptamer therapeutics |
| 06/14/2011 | US7960101 Method for using division arrested cells in screening assays |
| 06/14/2011 | US7960100 Colon cancer targets and uses thereof |
| 06/14/2011 | US7960099 White blood cell differentiation reagent containing an asymmetric cyanine fluorescent dye and method of use thereof |
| 06/14/2011 | US7960025 Magnetic nanoparticles comprising a core formed from noble metals |
| 06/14/2011 | US7959915 Inhibitors of extracellular Hsp90 |
| 06/14/2011 | US7959873 Biological detection based on differentially coupled nanomechanical systems using self-sensing cantilevers with attonewton force resolution |
| 06/14/2011 | US7959864 Downhole spectroscopic hydrogen sulfide detection |
| 06/14/2011 | US7959861 Integrated affinity microcolumns and affinity capillary electrophoresis |
| 06/14/2011 | US7959779 Macroscopically manipulable nanoscale devices made from nanotube assemblies |
| 06/14/2011 | US7959777 Devices, systems and methods for testing gas sensors and correcting gas sensor output |
| 06/14/2011 | US7959763 Apparatus and method for correcting basis weight measurements using surface topology measurement data |
| 06/14/2011 | US7959583 Integrated lancet and bodily fluid sensor |
| 06/14/2011 | US7959582 Method and apparatus for penetrating tissue |
| 06/14/2011 | US7959581 Test magazine and method for processing the same |
| 06/14/2011 | US7959565 Method and apparatus for estimating a likelihood of shoulder dystocia |
| 06/14/2011 | US7958775 Triboacoustic probe |
| 06/14/2011 | CA2724500A1 Sensor apparatus and method therefor |
| 06/14/2011 | CA2618305C Multi-layer strip for use in measuring biological material and system for measuring biological material |
| 06/14/2011 | CA2590559C Sensor-dispensing instruments |
| 06/14/2011 | CA2578680C Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining |
| 06/14/2011 | CA2478203C Encoded self-assembling chemical libraries (esachel) |
| 06/14/2011 | CA2475534C Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 06/14/2011 | CA2459354C Amplification and detection reagents for hiv-1 |
| 06/14/2011 | CA2452766C Carrier particle latex for assay reagent and assay reagent |
| 06/14/2011 | CA2443515C Methods and kits useful for the simplification of complex peptide mixtures |
| 06/14/2011 | CA2434442C Reflection-photometric analytical system |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2404618C Electrically-conductive patterns for monitoring the filling of medical devices |
| 06/14/2011 | CA2387788C Systems and methods for performing magnetic chromatography assays |
| 06/14/2011 | CA2361248C Detection of ligands by refractive surface methods |
| 06/14/2011 | CA2359705C Chromatographic process for purification of albumin |
| 06/14/2011 | CA2324853C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 06/14/2011 | CA2182621C Galanin receptor, nucleic acids, transformed cells and uses thereof |
| 06/14/2011 | CA2178212C Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 06/11/2011 | CA2724911A1 Fill sufficiency method and system |
| 06/10/2011 | CA2724942A1 Virally induced biofilm-like structure and uses thereof |
| 06/10/2011 | CA2688105A1 Virally induced biofilm-like structure and uses thereof |
| 06/09/2011 | WO2011069093A1 Detecting and counting tissue-specific stem cells and uses thereof |
| 06/09/2011 | WO2011069058A1 Methods for predecting and treating a sterile inflammation and discriminating between sterile and infective inflammation |
| 06/09/2011 | WO2011069056A2 Antennary fucosylation in glycoproteins from cho cells |
| 06/09/2011 | WO2011069031A2 Multiplanar lateral flow assay with sample compressor |
| 06/09/2011 | WO2011069029A2 Lateral flow assays |
| 06/09/2011 | WO2011069017A1 Method for incorporating internal polar and ionizable groups in proteins |
| 06/09/2011 | WO2011069014A1 Tox3 as a biomarker for breast cancer |
| 06/09/2011 | WO2011069009A1 Polyubiquitin levels as a prognostic indicator in leukemia |
| 06/09/2011 | WO2011069004A1 Mpl mutations in jak2 v617f negative patients with myeloproliferative disease |
| 06/09/2011 | WO2011068998A2 Systems and methods for determining hemoglobin concentration utilizing diffuse reflectance at isosbestic wavelengths |
| 06/09/2011 | WO2011068976A1 Gas sensor with compensation for baseline variations |
| 06/09/2011 | WO2011068956A2 Follistatin-like 3 (fstl3) levels in gestational diabetes |
| 06/09/2011 | WO2011068917A1 Qualifying a specimen for protein or peptide analysis |
| 06/09/2011 | WO2011068882A1 Breast cancer model systems |
| 06/09/2011 | WO2011068863A1 Combination therapy for treating cancer and diagnostic assays for use therein |
| 06/09/2011 | WO2011068844A1 Borrelia burgdorferi bacterial antigen diagnostic test using polymeric bait containing capture particles |
| 06/09/2011 | WO2011068841A1 Biological pathways associated with chemotherapy treatment in breast cancer |
| 06/09/2011 | WO2011068840A1 Methods for treating cancers comprising k-ras mutations |
| 06/09/2011 | WO2011068829A1 Biomarkers for determining an allograft tolerant phenotype |
| 06/09/2011 | WO2011068808A1 Enzymatic activity based-detection |
| 06/09/2011 | WO2011068801A2 Methods for identifying compounds that modulate ion channel activity of a kir channel |
| 06/09/2011 | WO2011068764A2 Apparatuses, systems, methods, and computer readable media for acoustic flow cytometry |
| 06/09/2011 | WO2011068758A1 Improved methods and compositions for detecting and treating cea-expressing cancers |
| 06/09/2011 | WO2011068720A1 Detecting hepatitis b virus mutants |
| 06/09/2011 | WO2011068707A1 Vitamin d metabolite determination utilizing mass spectrometry following derivatization |
| 06/09/2011 | WO2011068681A1 ASSAY FOR CARDIAC TROPONIN-T (cTnT) |
| 06/09/2011 | WO2011068680A1 Assay for diagnosis of cardiac myocyte damage |
| 06/09/2011 | WO2011068676A1 Peptide reagents and method for inhibiting autoantibody antigen binding |
| 06/09/2011 | WO2011068610A1 Methods for detecting risk of myelodysplastic syndrome by genotypic analysis |
| 06/09/2011 | WO2011068538A2 General method for generating ultra-high affinity binding proteins |
| 06/09/2011 | WO2011068466A1 Method and system for analysing a stained bio-specimen |
| 06/09/2011 | WO2011068340A2 Synthetic nonionic hydrophilic polymer-based prestained protein size marker |
| 06/09/2011 | WO2011068260A1 Microrna regulating the insulin signaling pathway, and method for screening material for controlling the action of a target thereof |
| 06/09/2011 | WO2011068221A1 Method for screening of substance capable of promoting recovery of skin barrier function |
| 06/09/2011 | WO2011068189A1 Method for detecting microorganisms belonging to mycoplasma pneumoniae and/or mycoplasma genitalium |
| 06/09/2011 | WO2011068176A1 Method for detecting cholangiocellular carcinoma and method of screening for prophylactic or therapeutic agent |
| 06/09/2011 | WO2011068166A1 Method of screening for agent for improving dry skin associated with atopic dermatitis employing activity of bleomycin hydrolase activity as measure |
| 06/09/2011 | WO2011068143A1 Antibody against influenza virus subtype h5 and use thereof |
| 06/09/2011 | WO2011068088A1 GENE EXPRESSION ANALYSIS METHOD USING TWO DIMENSIONAL cDNA LIBRARY |
| 06/09/2011 | WO2011068049A1 Blood coagulation analyzer |
| 06/09/2011 | WO2011067740A1 Use of secreted phospholipases a2 in the diagnosis and treatment of malaria |
| 06/09/2011 | WO2011067610A1 Diagnostic method for alzheimer's disease |
| 06/09/2011 | WO2011067597A1 Biomarkers of early miscarriage |
| 06/09/2011 | WO2011067587A1 Assay method and apparatus |
| 06/09/2011 | WO2011067563A1 Preparation of molecularly imprinted polymers |
| 06/09/2011 | WO2011067559A1 Biochemical analysis instrument |
| 06/09/2011 | WO2011067525A1 Method for determining the energy consumption of a lubricating oil of an internal combustion engine |
| 06/09/2011 | WO2011067516A1 Method for quick identification of viruses by means of mass spectrometry |
| 06/09/2011 | WO2011067420A1 Arf6 as a new target for treating alzheimer's disease |
| 06/09/2011 | WO2011067384A1 In vitro method for testing toxicity and efficacy of a test material to an ocular surface |
| 06/09/2011 | WO2011067377A1 Biochemical serum marker |
| 06/09/2011 | WO2011067243A1 Means and methods for diagnosing multiple sclerosis |
| 06/09/2011 | WO2011067202A1 Improved method for screening a potential modulator compound of a taste receptor |
| 06/09/2011 | WO2011067195A1 Biomarkers for predicting sustained response to hcv treatment |
| 06/09/2011 | WO2011066987A1 Methods of quantitative determination of neurogenesis in vivo |
| 06/09/2011 | WO2011066783A1 Anti-cyr61 protein monoclonal antibodies and uses thereof |
| 06/09/2011 | WO2011066655A1 Combined on-lattice/off-lattice optimization method for rigid body docking |